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Abstract
Background: The anatomical complexity of the horse’s head limits the abilities of radiography. Computed
tomography (CT) in combination with contrast enhanced CT is used more often for diagnosing various head
pathology in horses. The objective of this study was to compare intravenous and intra-arterial contrast-enhancement
techniques and describe normal and abnormal contrast enhancement in the horse’s head.
Results: All 24 horses included in the study recovered without complication from the procedures. Compared to the
pre-contrast studies, post-contrast studies showed significant contrast enhancement in the pituitary gland (IA:
p < 0.0001; IV: p < 0.0001), IA nose septum (p = 0.002), nose mucosa (IA: p < 0.0001; IV: p = 0.02), parotid salivary gland
(IA: p < 0.0001; IV p < 0.0001), cerebrum (IA: p < 0.0001; IV: p < 0.0001), rectus capitis muscle (IA: p < 0.0001; IV p = 0.001),
IA temporal muscle (p < 0.0001), IA masseter muscle (p <0.0001) and IV brainstem (p = 0.01). No significant contrast
enhancement was seen in the eye (IA: p = 0.23; IV p = 0.33), tongue (IA p = 0.2; IV p = 0.57), IA brainstem (p = 0.88), IV
nose septum (p = 0.26), IV temporal muscle (p = 0.09) and IV masseter muscle (p = 0.46). Three different categories of
abnormal enhancement were detected: a strong vascularised mass, an enhanced rim surrounding an unenhanced
structure and an inflamed anatomical structure with abnormal contrast enhancement.
Conclusion: Using the intra-arterial technique, similar contrast enhancement is achieved using less contrast medium
compared to the intravenous technique. And a potential major advantage of the IA technique is the ability to evaluate
lesions that are characterized by increased blood flow. Using the intravenous technique, a symmetrical and
homogenous enhancement is achieved, however timing is more crucial and the contrast dosage is more of
influence in the IV protocol. And a potential major advantage of the IV technique is the ability to evaluate
lesions that are characterized by increased vascular permeability. Knowing the different normal contrast
enhancement patterns will facilitate the recognition of abnormal contrast enhancements.
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Background
Radiography is a primary ancillary imaging modality for
the evaluation of the horse’s head. However, due to ana-
tomical complexity and superimposition of tissues of the
head, the interpretation of the radiographs remains diffi-
cult [1]. The tomographic ability to produce reconstructed
images allows computed tomography (CT) compared to
radiography to excel in depicting the complex anatomical
structures of the head [2].
Normal CT anatomy of the horse’s head has been de-
scribed in foals [3] and in adult horses [4]. In horses, CT
of the head has been used for the diagnosis of sinusitis,
alveolitis and apical infection of the check teeth [5, 6],
mandibular, nasal and paranasal tumors and cysts [7–9],
ethmoid hematoma [10], parapharyngeal aneurysm [11],
fractures [12–14], temporohyoid osteopathy [12], neuro-
logic [15] and intracranial disorders such as abscesses
[16], acute haemorrhage and other space-occupying
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masses [13, 17], and is routinely performed in such
cases. Contrast media are used to perform contrast-
enhanced CT examinations to accurately locate masses in
the head, fully depict the extension of space occupying
diseases in these areas and help plan the surgical approach
[7, 18, 19]. Contrast enhancement CT after intravascular
contrast medium administration is based on the principle
of an increased opacity in (neo-) vascularized structures
and extra-vascular structures in comparison to the native
CT study [20, 21]. In small animals, contrast-enhanced
CT of the head is common practice following an intraven-
ous route of contrast administration [22–25]. Contrast-
enhanced CT helps in these cases to differentiate normal
soft tissues from lesions in the soft tissues as soft tissue
lesions show an alteration in their blood flow and/or have
an altered vascular permeability [26].
In horses, two routes of intravascular contrast injec-
tion have been reported. The most common is the total
body systemic intravenous (IV) route as described in
small animals. A systemic bolus of contrast medium is
administered intravenously; the contrast medium will
pass the heart first and will be diluted before reaching
the region of interest. In small animals a protocol of
2 mL/kg body weight (~600mgI/kg body weight) of
intravenous contrast medium injected at a rate of 2 mL/s
has been established [22, 24, 25]. For horses this protocol
is more costly and impractical due to the large volume
that needs to be injected. In the equine literature several
protocols with a wide range of volumes and dosages
(250–400 mL of 350–370mgI/mL or about 160–250mgI/
kg body weight) have been described for horses [9, 13, 27].
A second route is intra-arterial (IA) contrast enhanced
CT, which has been described to characterize distal limb
conditions [20, 21] and more recently has been presented
for the horse’s head [28]. The advantage of the direct route
of intra-arterially administration of contrast medium is a
local high vascular concentration in the region of interest.
In the publications a standardized protocol using continu-
ous IA infusion at a rate of 2 mL/s while scanning an
entire volume (the distal limb or the head) beginning 3 s
before initiation of the CT scan, injecting a volume of less
than 200 mL is described [20, 21, 28].
The first purpose of the current study is to describe
and compare the normal contrast enhancement of the
soft tissue structures after systemic IV and direct IA ad-
ministration of contrast medium. The second purpose is
to describe the differences in abnormal contrast enhance-
ment between the two techniques. We hypothesised that
1) after IV or IA contrast administration, post-contrast
CT images show significant enhancement of the selected
soft tissue structures compared to the pre-contrast CT
images, 2) while using less contrast medium with the IA
technique, a similar or higher contrast enhancement will
be obtained as with the IV technique and 3) both
technique would allow to detect some specific abnormal
contrast enhancement patterns.
Methods
Study design
Retrospective comparative clinical study, ethical committee
oversight is currently not required for this type of study.
Cases
Case records were reviewed for horses, which underwent
native CT and intravascular (IV or IA) contrast-
enhanced CT evaluation of the head. All horses that
underwent IA contrast-enhanced CT were included. A
selection of IV contrast-enhanced cases was made based
on the present of a complete CT evaluation of the head.
Computed tomographic examination
CT scans of the head were acquired with the horses
under general anaesthesia. Each horse was sedated using
detomidine1 (0,005 mg/kg) as a premedication. Anaes-
thesia was induced with a combination of ketamine2
(2,2 mg/kg, IV) and midazolam3 (0,06 mg/kg, IV). After
intubation, anaesthesia was maintained with inhaled
isoflurane4 and oxygen (on effect, ±1,2 % expiratory).
Vital parameters like heart rate, ECG, respiratory rate
and respiratory curve were monitored continuously.
The horses were positioned in dorsal recumbency with
the head in the gantry. Images were acquired with two
fourth generation 4-slices helical CT scanners (Linge-
hoeve Equine Clinic: Philips Mx8000 Quad multislice
CT scanner5; Ghent University: GE Medical Systems
Prospeed four slice6) using the in-house protocols for
equine head imaging (Lingehoeve Equine Clinic: 120 kV,
185mAs, pitch 1, 1,3 mm slices, 512x512 matrix, scan
FOV 293–463 mm, sharp algorithm; Ghent University:
120 kV, 160mAs, pitch 1, 1,25–2,5 mm slices, 512x512
matrix, scan FOV between 192 and 403 mm, bone and
standard algorithm).
A pilot study was performed first to assess the symmet-
ric position of the horse’s head in the gantry, followed by
pre- and post-contrast CT studies in all horses.
IA contrast protocol
IA contrast-enhanced CT studies were performed after
aseptic ultrasound guided (7,5mHz linear probe)
catheterization (14 gauge x 80 mm) of one of the common
carotid arteries in the mid to caudal cervical region
through the skin, with the bevel directed towards the
heart. The common carotid artery was located deep to the
jugular vein and color Doppler helped to confirm the ar-
terial nature of the blood vessel. The catheter was intro-
duced trough the thick wall of the carotid artery in one
fast and strong movement. The catheter was fixed to the
skin with polypropylene sutures. A three-way stopcock
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and an extension set were attached to the catheter to
facilitate injection. The extension set was prefilled with
contrast medium before attaching to the catheter. A pres-
sure injector containing 250 ml of non-ionic iodinated
contrast medium was connected to the extension set. A
continuous arterial infusion protocol during scanning was
used, with an injection rate of 2 mL/s (total volume
injected <180 mL) of Ioversol 350mgI/mL (Optiray®3507).
The post-contrast scan was initiated with a 3 s delay from
the start of the contrast medium administration. The
intra-arterial catheter was removed at the end of the pro-
cedure and a 5-min manual compression was applied to
avoid bleeding and hematoma formation. Then a bandage
with moderate compression was placed around the neck
at the site of injection for the time of the recovery.
IV contrast protocol
IV contrast-enhanced CT studies were performed after
blind catheterization (18 gauge x 80 mm) of one of the
cephalic veins in the thoracic limbs, with the bevel
directed away from the heart. The catheter was fixed to
the skin with superglue. Two pressure injectors contain-
ing 200 ml of non-ionic iodinated contrast medium were
connected to an extension set. The extension set was
prefilled with contrast medium before attaching to the
catheter. A systemic bolus of 400 mL of Iobitridol
350mgI/mL (Xenetix®3508) was injected at a rate of
15 mL/s. The post-contrast scan was initiated about 30s
after the start of the contrast medium administration.
After removal of the catheter a bandage with moderate
compression was placed around the limb at the site of
injection for the time of the recovery.
Image analysis
Image analysis was performed separately by two of the
authors on a dedicated diagnostic imaging viewing sta-
tion with a 2880x1800 pixel flat screen monitor using
Osirix9 DICOM viewer software. Images were reviewed
using a soft tissue (window wide (WW): 200–400
Hounsfield Unit (HU); window level (WL): 40–100 HU)
and a bone window (WW: 2000 HU; WL: 750 HU). The
post-contrast images were evaluated using a soft tissue
window to review the normal pattern of contrast en-
hancement and to describe the abnormal enhancement
due to pathology. A semi-quantitative grading scale was
used to describe (abnormal-) contrast enhancement in
the different soft tissue structures: none (no enhance-
ment), mild (minimal enhancement), moderate (appar-
ent enhancement) and severe (obvious enhancement).
Circular semi-automatic region-of-interest (ROI’s) (size:
~0,5 cm2) were manually placed on predefined normal
soft tissue structures on the contrast enhanced images,
as illustrated in Figs. 1 and 2 using the sharp (IA studies)
and standard (IV studies) algorithm. To increase to
repeatability of the ROI placement, only easily identifi-
able soft tissue structures were reviewed in this study,
on which the ROI’s could be placed completely isolated
from adjacent structures. To ensure that the ROIs con-
tained mainly the parenchyma of the soft tissue struc-
tures, we avoided inclusion of macroscopic vessels
visible in the structures. The areas of interest in the soft
tissue structures were selected on 4 different transverse
slides. The most rostral selected slide at the level of the
first molars (Figs. 1a and 2a), allowed reviewing the epi-
thelial lining of the nasal conchae, the nasal septum and
the tongue as well as the body of the masseter muscle.
On the second slide, at the mid level of the orbita the
corpus vitreum of the eyes was reviewed (Figs. 1b and
2b). The third slide was selected at the level of the tem-
poromandibular joint (Figs. 1c and 2c), as at this level
the pituitary gland is anatomically situated, allowing the
review of the pituitary gland, the cerebral cortex, the
maxillary vein and the body of the temporal muscle. The
most caudal slide was selected at the level of foramen
magnum: the brainstem, the parotis salivary gland and
the body of the longus capitis muscle are easily identified
at this level (Figs. 1d and 2d). To assure the ROI’s on the
pre- and post contrast images were incorporating the
same tissue, the ROI’s were copied and pasted to the
pre-contrast images. The mean value registered in the
ROI’s was recorded and used for the quantification of
contrast enhancement in the selected normal soft struc-
tures. If structures were not incorporated in the CT
study due to a partial study of the head or if a structure
was obliterated by pathology e.g., due to a mass effect,
ROI’s were not placed on these structures.
Statistical analysis
A mixed model analysis was conducted for each separate
anatomical structure (dependent variable).10 Independent
fixed effects were the effect of observer (one or two),
contrast medium (yes or no), route of contrast
medium administration (IV or IA) and, if the structure
was measured bilaterally, asymmetry (side of the catheter
or contralateral side). Patient was included as random
effect. Homoscedasticity and normality of residuals were
visually checked using residuals versus fitted plots and
QQ plots. If necessary, power transformations were ap-
plied, using a Box-Cox plot for guidance. A P-value <0,05
(linear mixed model) was considered significant.
Results
Eleven warmblood horses and 1 Arabian horse that
underwent IA contrast-enhanced CT of the head at Linge-
hoeve Equine Clinic were identified, 7 geldings, 3 mares
and 2 stallions, median age of 8,5 years (range between 1
and 18 years). A group of 12 horses (10 warmblood
horses, 1 trotter and 1 pony) that underwent IV contrast-
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enhanced CT evaluation of the complete head at the De-
partment of Medical Imaging of the Faculty of Veterinary
Medicine of Ghent University were selected for the study.
Four geldings, 7 mares and 1 stallion, median age 14 years
(range between 4 and 25 years), median weight 540 kg
(range between 375 and 695 kg).
The CT diagnoses of the included cases were: apical
infections in combination with secondary sinusitis (n = 6),
ethmoid hematoma (n = 4), sinus cyst (n = 3), mass/neo-
plasm (n = 2), inflammatory/infectious disease (n = 2),
traumata (n = 1) bilateral temporohyoid osteoarthropathy
(n = 1) and no diagnosis (n = 5) (Table 1).
The first attempt catheterization of the common carotid
artery was not fully successful leading to hematoma for-
mation. The reason of the hematoma formation was a
hesitant introduction of the catheter through the thick
arterial wall and probably dissection of the wall with leak-
age of blood from the arterial lumen. The procedure was
still pursued and no harmful side effects were observed
for the patient.
All horses recovered without complications, no ad-
verse reactions on the contrast medium administrated or
administration technique were observed in the included
patients.
Normal contrast enhancement
IA protocol
During the IA injection of contrast medium, there was
moderate to severe contrast enhancement of the maxillary
veins (Table 2). In this group, the contrast enhancement
was asymmetrical between injection side and the contra-
lateral side in all cases (Figs. 1 and 3). In the maxillary
Fig. 1 Transverse IA contrast enhanced CT images of the equine head (right is to the left and dorsal is to the top). a At the level of the 09’s, ROI’s
are placed on the epithelial lining of the ventral nasal conchae (1), the nasal septum (2), the tongue (3) and the masseter muscles (4). Note the
homogeneous (star) and inhomogeneous and patchy (diamond) enhancement pattern in the nasal septum. b At the level of the eyes, ROI’s are
placed on the corpi vitreum (5). c At the level of the temporo-mandibular joints, ROI’s are placed on the pituitary gland (6), the cerebral cortex
(7), the maxillary veins (8) and the temporal muscles (9). d At the level of foramen magnum, ROI’s are placed on the parotid salivary gland (10),
the longus capitis muscles (11) and the brainstem (12). Note the different ROI’s placed on the grey matter (circle) and white matter (doted circle)
of the cerebrum and brainstem in figures (c) and (d)
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veins ipsilateral to the side of intra-arterial injection, part
of the contrast medium was seen pooling along the
dependant wall of the vein creating a layered and partial
severe contrast enhancement in the lumen of the vein
in 7 of the 12 cases. In 4 of these patients this layer
of non-mixed contrast medium occupied about 50 %
of the lumen. In the other 3 patients the layer of
contrast medium occupied about 25 % of the lumen
of the vein. In the maxillary vein contralateral to the
side of injection, no such dependant contrast medium
layer was detected in any case. Enhancement in this
vein was considered moderate and homogeneous
(Table 2, Fig. 3).
Mild to moderate contrast enhancement was seen and
measured for the pituitary gland (p < 0.0001), nose
septum (p = 0.002), nose mucosa (p < 0.0001) and parotid
salivary gland (p < 0.0001) (Table 2). Two different
enhancement patterns of the nose septum and nose mu-
cosa were observed in the included cases. In 7 cases the
enhancement was mild, homogeneous and symmetrical.
In 2 cases the enhancement was inhomogeneous, patchy
and not always symmetrical (Fig. 1).
On the post-contrast scans the cerebral arteries became
asymmetrical and more clearly visible on the ipsilateral
side of injection during IA contrast administration (Fig. 1).
The cerebrum showed only none to mild contrast en-
hancement (p < 0.0001). None to mild contrast enhance-
ment was also only measured, but not detected while
visually reviewing the cases for the rectus capitis muscles
(p < 0.0001), temporal muscles (p < 0.0001) and masseter
muscles (p = 0.001).
No significant contrast enhancement was detected in
the corpus vitreum (p = 0.23), the brainstem (p = 0.88)
and the tongue (p = 0.12) (Table 2).
Fig. 2 Transverse IV contrast enhanced CT images of the equine head (right is to the left and dorsal is to the top). a At the level of the 09’s, ROI’s
are placed on the epithelial lining of the ventral nasal conchae (1), the nasal septum (2), the tongue (3) and the masseter muscles (4). Note the
air opacities (star) in the mild enhancing and swollen right masseter muscles. b At the level of the eyes, ROI’s are placed on the corpi vitreum (5).
c At the level of the temporo-mandibular joints, ROI’s are placed on the pituitary gland (6), the cerebral cortex (7), the maxillary veins (8) and the
temporal muscles (9). d At the level of foramen magnum, ROI’s are placed on the parotid salivary gland (10), the longus capitis muscles (11) and
the brainstem (12). Note the rim enhancement (arrows) surrounding a hypodense retropharyngeal abcess (diamond). Note the different ROI’s
placed on the grey matter (circle) and white matter (doted circle) of the cerebrum and brainstem in figures (c) and (d)
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IV protocol
After IV injection of contrast medium, moderate, homo-
geneous and symmetric between the right and left side
in all cases, independently of the catheter side was
detected (Figs. 2 and 3) and measured (Table 2).
Mild to moderate contrast enhancement was seen and
measured for the pituitary gland (p < 0.0001), nose mu-
cosa (p = 0.02) and parotid salivary gland (p < 0.0001)
(Table 2). Mild to moderate contrast enhancement was
only seen and measured in the nose septum, but this
Table 1 Anamnesis of the horses included in the study, contrast administration protocol used and final (CT) diagnosis
Case Breed Age Sex Reason to perform the
scan
IV/IA Diagnosis Enhancement
1 WB 17 G Intermittent unilateral
epistaxis
IA 2 mL/s No significant abnormalities x
2 WB 8 M Headshaking IA 2 mL/s Widened infraorbital canal,
remaining tooth fragments
x
3 WB 4 G Unilateral nasal discharge IA 2 mL/s Ectopic tooth, apical infection x
4 WB 1 M Facial swelling, difficulty
breathing
IA 2 mL/s Sinus cyst Mild enhancement of the capsule
5 WB 4 G Facial swelling, unilateral
nasal discharge
IA 2 mL/s Inflammatory/infectious disease
with intra-cranial extension
Irregular enhancement of the trigeminal
nerve and soft tissue enhancements
surrounding the osteolysis
6 Arabian 11 S Soft tissue mass soft
palate
IA 2 mL/s Squamous cell carcinoma Heterogeneous enhancement of the
mass
7 WB 14 G Swelling behind left
mandible
IA 2 mL/s Soft tissue mineralisation’s, bilateral
TMJ disease,
x
8 WB 18 S Bilateral sinusitis IA 2 mL/s Progressive ethmoidal hematoma Very mild enhancement
9 WB 8 M Infectious process IA 2 mL/s Fractured right external acoustic
meatus
x
10 WB 9 G Opacity in the frontal sinus IA 2 mL/s Sinus cyst x
11 WB 6 G Unilateral nasal discharge IA 2 mL/s Apical infection, tooth fracture
and secondary sinusitis
x
12 WB 1 G Facial swelling, unilateral
nasal discharge
IA 2 mL/s ameloblastoma x
13 WB 10 M Epistaxis after surgery IV 241
mgI/kg
Subcutaneous emphysema x
14 WB 19 M Study IV 305
mgI/kg
No significant abnormalities x
15 Trotter 22 G Unilateral nasal discharge
with decreased air passage
IV 281
mgI/kg
Progressive ethmoidal hematoma
with secondary sinusitis
Adjacent mucosal enhancement
16 WB 8 M Unilateral nasal discharge IV 216
mgI/kg
Apical infection with abscess Mild enhancement of the capsule
17 WB 16 M Intermitted unilateral
epistaxis
IV 311
mgI/kg
Progressive ethmoidal hematoma Very mild enhancement
18 WB 9 G Difficulty breathing IV 252
mgI/kg
Sinus cyst Mild enhancement of the capsule
19 Pony 4 S Facial swelling IV 373
mgI/kg
Alveolitis x
20 WB 25 G Intermitted unilateral
epistaxis
IV 201
mgI/kg
Progressive ethmoidal hematoma Rim enhancement
21 WB 10 M Unilateral nasal discharge IV 219
mgI/kg
Alveolitis with secondary sinusitis x
22 WB 16 M Epilepsy IV 257
mgI/kg
No significant abnormalities x
23 WB 9 M Epilepsy IV 260
mgI/kg
No significant abnormalities x
24 WB 22 G Maxillary swelling IV 279
mgI/kg
Inflammation of the right masseter
musc. With abcess
Mild homogeneous enhancement of
the musc and rim enhancement
surrounding an abcess
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enhancement was not significant (p = 0,26) in the entire
group. Two different enhancement patterns of the nose
septum and nose mucosa were also observed in this
group. In 7 cases the nose mucosa and in 5 cases the
nose septum showed mild, homogeneous and symmetrical
enhancement (Fig. 2). In 4 cases the enhancement was
inhomogeneous, patchy and not always symmetrical. And
in 2 cases the nose septum showed no clear enhancement.
On the post-contrast scans the cerebral arteries became
mild and symmetrical visible after IV injection of contrast
medium (Fig. 2). The cerebrum was only none to mild con-
trast enhancing (p < 0.0001) (Table 2). None to mild contrast
enhancement was also only measured, but not detected
while visually reviewing the cases for the rectus capitis mus-
cles (p = 0.001) and the brainstem (p = 0.01) (Table 2).
No significant contrast enhancement was detected in the
corpus vitreum (p = 0.33), temporal muscles (p = 0.09), mas-
seter muscles (p= 0.46) and the tongue (p = 0.57) (Table 2).
Comparing the IA and IV protocol
The eye (p = 0.02), the pituitary gland (p = 0.05), longus
capitis muscles (p = 0.02) showed a significant higher in-
crease in attenuation for the IA protocol compared to
the IV protocol (Table 2).
Comparing the two observers
A significant difference in measurements between the two
observers was detected for the cerebrum (p < 0.0001) and
brainstem (p < 0.0001) only (Figs. 1 and 2).
Abnormal contrast enhancements
Abnormal contrast enhancement was reported in 4 cases
after IA contrast medium administration and in 6 cases
after IV contrast medium administration (Table 1). In
these reported cases, the detected abnormal contrast en-
hancements could be divided in three categories: a strong
vascularised mass (Fig. 4), an enhanced rim surrounding
an unenhanced structure (Figs. 2d and 5) and a normal
but inflamed anatomical structure highlighting a region
with increased vascular perfusion and permeability (Fig. 6).
No differences in these abnormal contrast enhancement
patterns were identified between the IV and IA protocols.
Discussion
In this study the use of IA and IV contrast enhanced CT
of the equine head was described using clinical cases.
Several studies have described the use of contrast
medium in horses [9, 13, 20–22, 26, 27], however the
different routes of contrast administration have not been
Table 2 The median and range of the HU measurements of the different structures, ipsilateral and contralateral of the injection site,
on the pre- and post-contrast CT images for the intravenous and intra-arterial protocols
Structure Injection Side Intravenous Protocol Intra-arterial Protocol
n Pre-Contrast (HU) Post-Contrast (HU) n Pre-Contrast (HU) Post-Contrast (HU)
Maxillary vein Ipsilat. 12 63.8(34.9–90.7) 109.7(81.3–146.5) 12 62.3(43.2–97.1) 307.9(91.8–2587.6)
Contralat. 12 63.0(36.7–97.8) 104.3(67.9–151.4) 12 61.0(48.7–80.7) 112.6(66.6–241.4)
Pituitary gland N/A 12 47.5(38.5–66.6) 78.7(58.6–100.0)a 12 57.2(34.7–108.0) 83.8(56.5–182.2)a
Nose septum N/A 9 68.5(32.5–115.0) 81.9(61.9–120.9) 11 67.6(50.5–108.1) 97.3(63.2–142.4)a
Nose mucosa Ipsilat. 9 64.0(24.8–134.5) 83.7(23,3–142.5)a 10 48.2(40.0–92.4) 77.7(40.9–125.5)a
Contralat. 8 63.2(14.4–128.6) 89.8(36.3–127.3)a 10 56.6(27.3–98.6) 86.1(30.3–148.0)a
Parotis salivary gland Ipsilat. 12 44.7(24.3–61.1) 62.0(37.6–97.7)a 8 42.0(32.4–55.5) 62.9(37.2–95.6)a
Contralat. 12 47.7(32.9–61.7) 66.3(37.8–110.5)a 8 43.7(33.7–53.8) 65.5(32.3–93.7)a
Cerebrum Ipsilat. 12 40.0(30.5–55.0) 41.4(29.8–56.4)a 12 38.2(31.4–53.8) 45.7(33.2–64.4)a
Contralat. 12 40.5(30.2–53.0) 44.8(31.4–56.1)a 12 38.7(30.4–67.0) 45.8(35.2–91.1)a
Longus capitis musc. Ipsilat. 12 46.3(19.6–59.8) 52.1(23.6–65.1)a 8 52.2(30.7–58.9) 57.3(43.5–95.3)a
Contralat. 12 50.8(32.9–66.4) 54.6(36.0–67.1)a 8 51.1(35.7–57.8) 62.0(50.3–83.9)a
Temporal musc. Ipsilat. 12 66.5(47.7–87.7) 69.3(50.0–91.8) 12 68.4(46.9–81.7) 73.7(59.4–91.0)a
Contralat. 12 66.1(44.6–79.6) 67.8(49.8–97.0) 12 67.3(47.3–76.6) 75.3(55.2–92.0)a
Masseter musc. Ipsilat. 9 79.4(50.8–125.8) 85.3(53.5–140.0) 11 85.5(55.6–98.6) 91.0(67.8–154.5)a
Contralat. 9 79.3(55.5–128.6) 83.0(59.8–129.0) 11 84.7(52.4–105.4) 84.9(59.7–149.6)a
Corpus vitreum Ipsilateral 11 14.9(4.2–25.9) 15.7(8.3–25.8) 11 9.7(2.7–20.9) 11.2(3.3–24.8)
Contralat. 12 15.3(4.6–28.8) 14.8(5.6–23.4) 11 8.7(2.8–21.0) 8.5(1.5–39.8)
Brainstem N/A 12 44.7(31.6–64.4) 48.3(33.6–67.4)a 8 39.8(23.0–68.0) 40.0(21.5–75.2)
Tongue N/A 9 55.7(23.2–103.2) 62.2(24.4–107.4) 11 48.4(17.8–78.4) 56.3(27.7–81.2)
n amount of structures measured, HU Houndsfield Unit; a Significant increase in contrast enhancement between pre- and post contrast scans
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compared. As we used two different scanners in this study,
interscanner variability needed to be considered [29].
The absolute attenuation values of the studied structures
were only used to determine the structures enhancement
and are not directly compared between the two scanners.
The contrast medium administration protocols and scan-
ners were consistent pairs. In the presence of interscanner
or intrascanner variability, significant differences in
enhancement can therefore not be explained without
considering differences between the two protocols.
It was hypothesized that, the IA contrast medium
administration technique would result in a similar or
higher contrast enhancement using a lower volume of
contrast medium compared to the IV technique. Contrast
enhancement of a structure is intrinsically depending on
its specific anatomy and vascular supply, extrinsically on
the local dose of contrast medium and the timing of injec-
tion relative to the scan protocol. In the described study
no controls were performed to exclude the influence of
the individual case’s intrinsic properties on contrast
Fig. 3 Transverse pre-contrast (a), IA post-contrast (b) and IV post-contrast (c) CT images at the level of the temporo-mandibular joints (right is to
the left and dorsal is to the top). a The visibility of the vascular structures are less clear definite compared to the post-contrast images, especially
the smaller arterial structures (A and T) are more difficult to distinguish from the surround soft tissue. b Bilateral contrast-enhancement after unilateral
left-sided intra-arterial contrast injection is clearly delineating the vascular structures; contrast streaming is seen in the left maxillary vein.
c Homogenous, bilateral contrast-enhancement of the arterial and venous vascular structures after intra-venous contrast injection. TMJ:
temporomandibular joint; H: pituitary gland; A: maxillary artery; V: maxillary vein; T: truncus linguofacialis; L: linguofacial vein
Fig. 4 Transverse CT and IA contrast enhanced CT images of case 6 (right is to the left and dorsal is to the top). a Squamous cell carcinoma in
the hard palate causing a mass effect in the left ventral nasal meatus (cross) and suppressing the left ventral conchal sinus (diamond). The hard
palate and the alveolar bone of elements 209 and 210 are destructed. b Heterogeneous contrast enhancement of the mass, enhancement of the
mass is indicated by the arrows and non-enhancing portion of the mass are indicated by arrowhead
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enhancement of the different structures. Recognising this
shortcoming, we assume differences in contrast enhance-
ment was only influenced by the extrinsic properties.
The local contrast medium dose compared to the total
dose administered and the influence of timing are differ-
ent for the two techniques. The local contrast medium
dose in the IV technique is influenced by the amount of
contrast medium injected as a bolus and the systemic di-
lution (influenced mainly by the size of the individual in
combination with blood pressure) of this bolus. In the
IA technique the dose of contrast medium in the common
carotid artery is only influenced by the local dilution with
the blood in the common carotid artery at the moment of
injection.
Timing of injection relative to the scan protocol for
the IV technique is crucial as selective arterial enhance-
ment, the so called “first pass”, is only seen for a relative
short period. In human a 10 s time-window of selective ar-
terial enhancement of the carotid arteries was identified
20 s after the start of the intravenous contrast medium
bolus administration [30]. The results of the present study
showed semi-quantitative moderate to severe enhancement
Fig. 5 Transverse CT and IV contrast enhanced CT images of two cases with a sinus cyst (right is to the left and dorsal is to the top). a Native CT
image showing a fluid filled right caudal maxillary and conchofrontal sinus (circle). b Contrast enhanced CT image at the same level as image A,
showing a thin mild contrast enhancement of the capsule (arrows). c Native CT image showing a fluid filled right caudal maxillary and frontal
sinus (cross), a partial mineralised capsule is detected (arrows). d Contrast enhanced CT image at the same level as image C, showing the partial
mineralised capsule (arrows) with an adjacent moderate contrast enhancement (arrowheads) revealing a much thicker capsule
Fig. 6 Transverse CT and IV contrast enhanced CT images of case 15 (right is to the left and dorsal is to the top). a Secondary sinusitis in the right ventral
conchal sinus (circle) characterised by mucosal thickening and free fluid (fluidline). b Adjacent mucosal contrast enhancement (arrow heads) is detected
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of both the arterial and the venous system in all IV cases.
The continuous injection of the IA protocol is assuring the
visibility of contrast medium in the arterial lumen. As pre-
viously seen for the distal limb, the short delay before initi-
ation of the scan and the time needed to scan the entire
head is assuring contrast enhancement of the vascular bed,
possible extravascular structures [20, 21] and as shown in
the results the venous system. Based on these findings,
both techniques represent a mixed (arterial and delayed)-
phase CT angiography.
Our results showed for both techniques a similar semi
quantitative ranking from highest to least enhancing
structures. Highest enhancement and extreme outliers
were seen in the maxillary veins. Due to these extreme
outliers, statistical analysis was not considered useful.
Streaming was the cause of these outliers in the maxillary
veins. Streaming is visible as the layered appearance of
highly attenuating contrast medium and blood in the
vasculature due to the lack of optimal mixing. This
phenomenon was detected in both the arterial and venous
systems in the IA group. In the arterial system, streaming
has previously been reported after intra-arterial drug ad-
ministration and depends on the rate of infusion, the type
of catheter used and the position of the catheter in relation
to the arterial branching [31]. Streaming in the venous sys-
tem has previously been reported to occur in the portal
vein following direct injection of contrast medium in the
splenic parenchyma in dogs [32]. However, in several cases
streaming was present in the venous system and absent in
the arterial system after intra-arterial contrast administra-
tion. An explanation is lacking for this observation.
The major arteries that supply blood to the head are
the both common carotid arteries (left and right side of
the head) and the basilar artery (brainstem, cerebellum
and caudal cerebrum) [33–35]. Both protocols differ
based on the arterial supply of contrast rich blood to the
head. The intravenous protocol is non-selective, using
both common carotid arteries and the basilar artery,
compared to selective intra-arterial protocol, using only
one common carotid artery. As only in the IV group a
small statistical significant difference in enhancement of
the brainstem was measured in this study, the ability of
the IA protocol to supply contrast rich blood to the
brainstem, cerebellum and caudal cerebrum should be
considered a potential limitation of the protocol. How-
ever in horses, in contrast to other domestic animals
and humans, the common carotid arteries are divided
into three arteries (external carotid and internal carotid
but also the occipital artery). Via the occipital artery, that
is forming the cerebrospinal artery, contrast medium
injected in the common carotid artery is supplying the
basilar artery in horses [33–35]. Further research will be
needed to determine to amount of contrast medium
reaching the basilar artery through this connection.
Interestingly, homogenous contrast enhancement of
the nose mucosa, parotis salivary gland, cerebrum, tem-
poral muscles and masseter muscles was seen and/or mea-
sured in the IA group at the contralateral side following
unilateral contrast medium injection. This simultaneous
opacification is most likely the result of communications
between the right and left arterial systems, through the
caudal intercarotid artery and via the arterial circle of
Willis [33–36]. Regardless of the side of injection, the nasal
mucosa showed a significant enhancement bilaterally. As
such, horses with bilateral sinonasal disorders could pos-
sibly be scanned following a single arterial injection.
The pituitary gland, the nose septum and mucosa and
the parotid salivary gland are highly vascularised struc-
tures, which showed marked enhancement on most
post-contrast images. Previous reports described the ac-
curacy of delineating the pituitary gland of adult horses,
using 250 mL MD-76 (370mgI/mL) [27]. The higher
dose of IV contrast medium used in this study, 400 mL
Iobitridol (350mgI/mL), will probably not improve one’s
ability to detect the pituitary gland and the other marked
enhanced structures. However, for the nose septum and
mucosa, two patterns of contrast enhancement were ob-
served. In our experience the patchy pattern is more often
visible with an increasing dose of contrast medium. Due
to a local higher contrast medium concentration, this pat-
tern of enhancement is most likely highlighting the small
calibre blood vessels running in these structures. Interest-
ingly, no significant enhancement of the nose septum in
the IV group was detected, review of the data showed
almost no enhancement in several cases and moderate
enhancement in the other cases. Similar results were seen
for the temporal and masseter muscles. The absence of
significant enhancement in these structures is most likely
caused by the variation in contrast dosage (due to the dif-
ferences in bodyweight) between the individuals included
in this group.
The remaining structures had none to very mild signifi-
cant contrast enhancement. In none of these structures,
the enhancement was appreciated while reviewing the
cases. Increasing the local dose of contrast medium would
theoretically result in higher enhancements in these struc-
tures. Based on our results the absence of visible contrast
enhancement in these structures after contrast medium
administration using one of the above-described protocols
has to be considered normal.
A conspicuous finding in these un-enhancing struc-
tures is several higher attenuation measurements on
pre-contrast images compared to post-contrast images.
This is most likely due to small movements of the horses
in between scans. The copied ROI’s incorporated there-
fore not exactly the same tissue samples of the struc-
tures. This intra-patient variability has to be considered
if abnormal contrast enhancement is diagnosed.
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Comparing both techniques, the results display differ-
ent enhancements in three structures: the eye, pituitary
gland and rectus capitis muscle. Although all three
structures show a significant difference, for the eye and
pituitary gland, the median difference was very small
(1.1 and 0.4 HU respectively). For the rectus capitis
muscle the difference was higher (6.9 HU). This muscle
receives its blood supply directly from the common ca-
rotid arteries. A possible explanation for the detected
difference could be the streaming causing a local excep-
tionally high concentration of the contrast medium in
the blood supplied to the rectus capitis muscles.
Significant interobserver differences were only detected
for the measurements performed on the brain and brain-
stem. Placement of the ROI’s on these structures differed
between the two observers. Reviewing the ROI’s placed on
the brain did not allow to detect a difference in attenu-
ation (median interobserver difference of 4.5 HU), this in
accordance with previous reports [4]. In contrary de-
pending on the WW and WL setting used to review
the brainstem, the grey and white matter could clearly
be distinguished (median interobserver difference of
9.2 HU). Depending on the distance to the cranium
for the brain and the central or peripheral localisation
for the brainstem, an attenuation measurement is
made of the more attenuating grey matter (observer
2) or less attenuating white matter (observer 1).
In this study, mild or marked abnormal contrast
enhancement was seen in several cases. Three different
abnormal enhancement patterns where detected in the
included cases: enhancement due to the strong vascular-
isation of a soft tissue mass, rim enhancement of an
encapsulated structure and increased enhancement due
to inflammation of an anatomical structure. Diagnostic-
ally these findings help in the characterisation of a lesion
and in the delineation of the margins between normal
soft tissue and soft tissue lesions that are not always
evident on pre-contrast images [7, 13, 19]. Especially
contrast enhancement in structures, that are normally
not or only very mild enhancing, as previously described
for cerebral lesions [13, 15] and seen in case 5 and 24,
have to be considered abnormal. In none of the cases
with abnormal contrast enhancement both techniques
were simultaneously performed, therefor-direct compari-
son between the two protocols in demonstrating specific
lesions is not possible based on this study.
Some concerns may be raised for both techniques. In
the first case were catheterization of the common ca-
rotid artery was attempted this leaded to hematoma for-
mation. The wall of the common carotid artery is thick
and the introduction of the catheter should therefor be
done with a fast and strong movement to penetrate the
vessel wall. This procedure had a steep learning curve
considering the fact that only the first catheterization
was followed by the formation of a hematoma. A specific
concern for intra-carotid drug administration in humans
is cerebral embolism due to air emboli [31]. Carefully re-
moving air from the pressure injector and prefilling the
extention set prior to attaching to the catheter are provi-
sions to prevent air emboli. In human, a transient but
clinically tolerable increase in intra-arterial pressure of
the internal carotid and vertebral artery has also been
observed, following prolonged intra-arterial injection of
contrast medium [37]. In horses, an elevated mean arter-
ial blood pressure or heart rate were seen in 5 % of the
cases after intra-arterial iodinated contrast medium ad-
ministration without requiring intervention [38]. Intra-
arterial pressure was not monitored quantitatively in any
of the horses included in the study. Although volatile
agent-induced hypotension is well known and a concern
during inhalation anaesthesia in horses [39]. Our main
consideration not to monitor intra-arterial pressure was
to keep the total anaesthesia time as short as possible.
A second concern is the contrast medium induced
anaphylactic reactions, reported for several species in-
cluding horses [38, 40–42]. Mild reactions as an elevated
heart rate, changes in blood pressure, urticarial and
oedema are the most often seen symptoms. Excluding
these reactions in the study population solely based on
the clinical records is difficult, as for these conditions no
treatment or intervention is considered necessary [38,
42] and blood pressure is not standardly recorded in our
institutes during CT studies. Moderate and severe ana-
phylactic reactions require treatment or intervention
[38, 42]. No such reactions have been described in the
anaesthesia and clinical records of the included cases.
Conclusions
Either protocol used in this study showed similar
marked, mild or none obvious contrast enhancement de-
pending on the reviewed structure. The major advantage
of IA contrast medium administration during CT studies
is that a similar contrast enhancement is achieved with
less contrast medium compared to IV contrast adminis-
tration, with the disadvantage of the presences of con-
trast streaming. And a potential major advantage of the
IA technique is the ability to evaluate lesions that are
characterized by increased blood flow. The major advan-
tage of the IV contrast medium administration in the
cephalic vein is the symmetrical and homogenous en-
hancement, however timing is more crucial and the con-
trast dosage is more of influence in this protocol. And a
potential major advantage of the IV technique is the
ability to evaluate lesions that are characterized by in-
creased vascular permeability. Knowing the different
normal contrast enhancement patterns of the soft tissues
will facilitate the recognition of abnormal contrast en-
hancements in the horse’s head. Further research will be
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needed to identify indications specifically profiting from
either technique.
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